← Eichor
Condition: Testosterone Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Testosterone

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Puberty, Testosterone, and Brain Development
Phase N/A · 1 location(s) · University of Colorado, Denver · NCT06670053Effects of Cross-sex Hormone Therapy on Eating Behavior, Metabolism, Energy Balance and Cardiovascular System
Phase N/A · 1 location(s) · University of Leipzig · NCT04838249High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
Phase 2 · 17 location(s) · VA Office of Research and Development · NCT05011383Working Out M0 Bipolar Androgen Therapy
Phase 2 · 12 location(s) · Australian and New Zealand Urogenital and Prostate Cancer Tr · NCT06594926Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury
Phase 2 · 2 location(s) · North Florida Foundation for Research and Education · NCT04460872EndoPAT Device for Endothelial Dysfunction in ED
NA · 1 location(s) · University of California, Irvine · NCT06720597Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Phase 3 · 338 location(s) · SWOG Cancer Research Network · NCT0367802552 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male
Phase 3 · 20 location(s) · Halozyme Therapeutics · NCT06689085RecoverPC: Relugolix vs GnRH Agonist in Quality of Life
Phase 2 · 3 location(s) · Dana-Farber Cancer Institute · NCT05765500Testosterone and Neural Function
EARLY_Phase 1 · 1 location(s) · VA Office of Research and Development · NCT06130449Adolescent Mood During Puberty and Testosterone
NA · 1 location(s) · University of North Carolina, Chapel Hill · NCT06072677Testosterone Levels and Cutibacterium
Phase N/A · 1 location(s) · University of Washington · NCT05030220TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men
Phase 2 · 1 location(s) · Lomonosov Moscow State University Medical Research and Educa · NCT07460960Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer
Phase 4 · 1 location(s) · Roswell Park Cancer Institute · NCT06733350Estradiol and Testosterone Subdermal Implants for Menopause Treatment (ESTIME)
Phase 3 · 1 location(s) · University of Sao Paulo General Hospital · NCT06343870Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
Phase 2 · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT06059118Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response
Phase 2 · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT07142551New-onset Chronic Pelvic Pain in Transgender People Using Testosterone Therapy: an Exploratory Qualitative Study.
Phase N/A · 1 location(s) · University Hospital, Grenoble · NCT06487754Testosterone Supplementation in Patients in Best Supportive Care: Impact on Quality of Life
EARLY_Phase 1 · 1 location(s) · Jules Bordet Institute · NCT07143279Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression
Phase 2 · 6 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT04363164Effects of Early Testosterone Gel Administration on Physical Performance in the Critically Ill
Phase 2 · 5 location(s) · University Hospital, Clermont-Ferrand · NCT05825092Sex Steroids Balance for Metabolic and Reproductive Health in Klinefelter Syndrome
Phase 3 · 1 location(s) · Georgios Papadakis · NCT05586802Male Experiences With Intra Cytoplasmic Sperm Injection (ICSI) and Reduced Sperm Quality
Phase N/A · 1 location(s) · Peter Humaidan · NCT07546435A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Phase 1 · 25 location(s) · Astellas Pharma Global Development, Inc. · NCT04729114Transgender Men, Non-binary Persons and Testosterone Treatment BODY IDENTITY CLINIC
Phase N/A · 1 location(s) · Marianne Andersen · NCT04254354Determining INdividual Preferences for Gynecomastia avOidance (DINGO) - Stage 1
NA · 1 location(s) · St Vincent's Hospital, Sydney · NCT07552922Testosterone Deficiency and Endothelial Dysfunction After Spinal Cord Injury
Phase N/A · 1 location(s) · Craig Hospital · NCT07227740Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06096870Low to Moderate Load Power Training for Men With Metastatic Prostate Cancer.
NA · 1 location(s) · University of Alicante · NCT07572760The COSMYC Trial (COmbined Suppression of MYC)
Phase 2 · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT06922318
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.